| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/01/1996 | WO1995023225A3 Method and reagent for inhibiting the expression of disease related genes |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195531A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 02/01/1996 | CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | CA2195122A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | CA2195120A1 Wound healing formula |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2194991A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194873A1 Condii toxoplasma p30 expression cassette |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194561A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | CA2194493A1 Compositions and methods for a bioartificial extracellular matrix |
| 02/01/1996 | CA2194398A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 01/31/1996 | EP0694562A1 Preparation of alpha-1-antichymotrypsin |
| 01/31/1996 | EP0694561A1 Calcitonin analogue and use thereof |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694308A1 Cyclosporin-containing emulsion composition |
| 01/31/1996 | EP0694307A1 Atopic disease remedy |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694069A1 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0694066A1 Model for gonococcal infection |
| 01/31/1996 | EP0694044A1 Method and product for regulating cell responsiveness to external signals |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 01/31/1996 | EP0693941A1 Radiolabeled compounds for thrombus imaging |
| 01/31/1996 | EP0693940A1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells |
| 01/31/1996 | EP0693937A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693935A1 Method and compositions for digesting tissue |
| 01/31/1996 | EP0693934A1 Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 01/31/1996 | EP0693933A1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 01/31/1996 | EP0693932A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0634935A4 A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen. |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/31/1996 | EP0455785B1 Leucocyte elastasis and cathepsin g-blocking peptide |
| 01/31/1996 | EP0423322B1 Grf analogs viia |
| 01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | US5488047 Hypotensive agents, analgesics; congestive heart failure |
| 01/30/1996 | US5488037 Antithrombotic agents |
| 01/30/1996 | US5488036 Gonadotrophins in cells for polypeptide hormones |
| 01/30/1996 | US5488034 Pharmaceutical composition comprising BPI proteins |
| 01/30/1996 | US5488033 Treatment to reduce edema |
| 01/30/1996 | US5487984 Processes for producing tumor necrosis factor |
| 01/30/1996 | US5487982 Method of obtaining immunogenic peptides from cells expressing temperature-sensitive mutants of major histocompatibility complex molecules |
| 01/30/1996 | US5487979 DNA encoding human and murine eps15, a substrate for the epidermal growth factor receptor |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/30/1996 | US5487970 Compositions and methods for detecting gene rearrangements and translocations |
| 01/30/1996 | US5487916 Method for coating particles in a spray-drying plant |
| 01/30/1996 | US5487898 Compositions and method for the sublingual or buccal administration therapeutic agents |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | US5487890 Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof |
| 01/30/1996 | US5487889 Envelope encloses cells that secrete wound healing growth factors; genetic engineering |
| 01/30/1996 | CA1338011C Oncostatin m and novel compositions having anti-neoplastic activity |
| 01/26/1996 | CA2154141A1 Endothelin-antagonizing peptide |
| 01/26/1996 | CA2154129A1 Endothelin-antagonizing peptide |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001907A1 NOVEL p53 RESPONSE GENES |
| 01/25/1996 | WO1996001903A1 Fusion proteins comprising gm-csf and antigens and their expression in yeast |
| 01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | WO1996001901A1 Streptogramines and method for preparing same by mutasynthesis |
| 01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001894A1 Chondroitin lyase enzymes |
| 01/25/1996 | WO1996001893A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001844A1 Proteins associated with tumor necrosis factor receptor |
| 01/25/1996 | WO1996001843A1 Polypeptide produced by stromal cell |
| 01/25/1996 | WO1996001842A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | WO1996001841A1 Cationic lipids for delivery of nucleic acids to cells |
| 01/25/1996 | WO1996001840A1 Cationic lipids for delivery of nucleic acids to cells |
| 01/25/1996 | WO1996001839A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | WO1996001838A1 Jak3 protein tyrosine kinase and dna encoding the same |
| 01/25/1996 | WO1996001655A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | WO1996001649A1 Method of attenuating arterial stenosis |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001647A1 Anti-protozoan methods and materials |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |